Testing effectiveness (Phase 2)Study completedNCT03054909
What this trial is testing
IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer
Who this might be right for
FIGO Stage III and IV Ovarian CancerFIGO Stage III and IV Fallopian Tube CancerFIGO Stage III Primary Peritoneal Cancer
Masonic Cancer Center, University of Minnesota 7